KNC LABORATORIES CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for KNC LABORATORIES CO., LTD..The latest application filed is for "nucleic acid drug suppressing production of myostatin gene mrna".

Company Profile

5.14.13

KNC LABORATORIES CO., LTD. - Hyogo JP
KNC LABORATORIES CO., LTD. - Kobe-shi, Hyogo JP
KNC LABORATORIES CO., LTD. - Kobe N/A JP
KNC LABORATORIES CO., LTD. - Kobe-shi JP
KNC Laboratories Co., Ltd. - N/A

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nucleic Acid Drug Suppressing Production Of Myostatin Gene Mrna App 20220220478 - MATSUO; Masafumi ; et al.	2022-07-14
Inhibition Of Myostatin Signal By Myostatin Splice Variant-derived Protein And Utilization Thereof App 20220135637 - MATSUO; Masafumi ; et al.	2022-05-05
Oligonucleotides For Controlling Tau Splicing, And Uses Thereof App 20210230598 - SOBUE; Gen ; et al.	2021-07-29
Antisense oligonucleotide controlling expression amount of TDP-43 and use thereof Grant 11,028,390 - Nagai , et al. June 8, 2	2021-06-08
Production Of Highly Fat-soluble Phosphoramidite App 20210087220 - FUJIHARA; Tsuyoshi ; et al.	2021-03-25
Method for modifying T cell population Grant 10,899,790 - Sugiyama , et al. January 26, 2	2021-01-26
Antisense Oligonucleotide Controlling Expression Amount Of Tdp-43 And Use Thereof App 20200165610A1 -	2020-05-28
Method For Modifying T Cell Population App 20190284228 - SUGIYAMA; Haruo ; et al.	2019-09-19
Nucleic acid drug for inducing skipping of variant exon of CD44 gene and increasing expression of normal type CD44 mRNA Grant 10,174,319 - Matsuo , et al. J	2019-01-08
Phenoxyalkylamine compound Grant 9,771,316 - Kanai , et al. September 26, 2	2017-09-26
Nucleic Acid Drug For Inducing Skipping Of Variant Exon Of Cd44 Gene And Increasing Expression Of Normal Type Cd44 Mrna App 20170137810 - MATSUO; Masafumi ; et al.	2017-05-18
Phenoxyalkylamine Compound App 20150336876 - KANAI; Yoshikatsu ; et al.	2015-11-26
Bearing lubricant composition Grant 9,157,044 - Oda October 13, 2	2015-10-13
Polyamide Compound And Pharmaceutical Composition For Treating Mitochondrial Genetic Disease App 20150191571 - Yano; Takamitsu	2015-07-09
Thioxothiazolidine derivative having Ras function inhibitory effect Grant 9,056,862 - Kataoka , et al. June 16, 2	2015-06-16
Thioxothiazolidine Derivative Having Ras Function Inhibitory Effect App 20140194412 - Kataoka; Tohru ; et al.	2014-07-10
Bearing Lubricant Composition App 20130096042 - ODA; Akihiro	2013-04-18
Process for producing a concentrated solution for a photoresist-stripping liquid having low water content Grant 8,299,303 - Hirose , et al. October 30, 2	2012-10-30
ENA nucleic acid drugs modifying splicing in mRNA precursor Grant 7,902,160 - Matsuo , et al. March 8, 2	2011-03-08
Intermediates for synthesis of vitamin D derivatives Grant 7,598,408 - Imahori , et al. October 6, 2	2009-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.